{
    "accession": "ENCBS453UWP",
    "age": "15",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "episome",
            "purpose": "characterization",
            "reagents": [
                {
                    "identifier": "addgene:109035",
                    "source": "/sources/addgene/",
                    "url": "http://www.addgene.org/109035/"
                },
                {
                    "identifier": "addgene:109036",
                    "promoter_details": "synthetic minimal core promoter",
                    "source": "/sources/addgene/",
                    "url": "http://www.addgene.org/109036/"
                },
                {
                    "identifier": "thermo-fisher:MPK10096",
                    "source": "/sources/thermo-fisher/"
                }
            ]
        }
    ],
    "biosample_term_id": "EFO:0001187",
    "biosample_term_name": "HepG2",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [],
    "donor": "ENCDO000AAC",
    "health_status": "hepatocellular carcinoma",
    "lab": "Ryan Tewhey, JAX",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "passage_number": 7,
    "references": [],
    "sex": "male",
    "source": "ATCC",
    "summary": "Homo sapiens HepG2 cell line genetically modified (episome) using transient transfection, 24 hours post-nucleic acid delivery time",
    "treatments": []
}